請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56654
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鄭謙仁(Chian-Ren Jeng) | |
dc.contributor.author | Yenh-An Wu | en |
dc.contributor.author | 吳嶽安 | zh_TW |
dc.date.accessioned | 2021-06-16T05:40:12Z | - |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-12 | |
dc.identifier.citation | 邱明堂、鐘文彬、鄭謙仁、闕玲玲、龐飛。本省病死保育和肥育豬隻肺炎及肺臟內豬繁殖與呼吸道症侯群病毒成染狀況。中華獸醫誌 23:430-440, 1997
Abina, E., 1997. Epidemiology of porcine reproductive and respiratory syndrome (PRRS): an overview. Vet Microbiol 55, 309-316. Ansari, I.H., Kwon, B., Osorlo, F.A., Pattnaik, A.K., 2006. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol 80, 3994-4004. Bautista, E.M., Faaberg, K.S., Mickelson, D., McGruder, E.D., 2002. Functional properties of the predicted helicase of porcine reproductive and respiratory syndrome virus. Virology 298, 258-270. Bautista, E.M., Molitor, T.W., 1997. Cell-mediated immunity to porcine reproductive and respiratory syndrome virus in swine. Viral Immunol 10, 83-94. Bautista, E.M., Suarez, P., Molitor, T.W., 1999. T cell responses to the structural polypeptides of porcine reproductive and respiratory syndrome virus. Arch Virol 144, 117-134. Beura, L.K., Sarkar, S.N., Kwon, B., Subramaniain, S., Jones, C., Pattnaik, A.K., Osorio, F.A., 2010. Porcine reproductive and respiratory syndrome virus nonstructural protein Ibeta modulates host innate immune response by antagonizing IRF3 activation. J Virol 84, 1574-1584. Botner, A., Strandygaard, B., Sorensen, K.J., Have, P., Madsen, K.G., Madsen, E.S., Alexandersen, S., 1997. Appearance of acute PRRS-Iike symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet Rec 141, 497-499. Calvert, J.G., Slade, D.E., Shields, S.L., Jolie, R., Mannan, R.M., Ankenbauer, R.G., Welch, S.K., 2007. CD163 expression confers Susceptibility to porcine reproductive and respiratory syndrome viruses. J Virol 8l, 7371-7379. Cancel-Tirado, S.M., Evans. R.B., Yoon, K.J., 2004. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet Immunol Immunopathol 102, 249-262. Cano, J.P., Dee, S.A., Murtaugh, M.P., Pijoan, C., 2007a. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate. Vaccine 25, 4382-4391. Cano, J.P., Dee, S.A., Murtaugh, M.P., Trincado, C.A., Pijoan, C.B., 2007b. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs. Am J Vet Res 68, 565-571. Cavanagh, D., 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 142, 629-633. Chan, H.T., Chia, M.Y., Pang, V.F., Jeng, C.R., Do, Y.Y., Huang, P.L., 2013. Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana. Plant Biotechnol. J.11, 315-324. Charles, A. J., Paul. T., Mark, W., Mark, J. S., 2001. mmuno-biology: the immune system in health and disease. The mucosal immune system. 10-13~l0-20 5th ed. Published by Garland Publishing. Chen, Z., Lawson, S., Sun, Z., Zhou, X., Guan, X., Christopher-Henninngs, J., Nelson, E.A., Fang, Y., 2010a. Identification of two auto-cleavage products of nonstructural protein 1 (nspl) in porcine reproductive and respiratory syndrome virus infcted cells: nspl function as interferon antagonist. Virology 398, 87-97. Chen, Z., Zhou, X., Lunney, J.K., Lawson, S., Sun, Z., Brown, E., Christopher-Hennings, J., Knudsen, D., Nelson, E., Fang. Y., 2010b. Immunodominant epitopes in nsp2 of procinc reproductive and respiratory syndrome virus are dispensable for replication, but play an important role in modulation of the host immune response. J Gen Virol 91, 1047-1057. Chia, M.Y., Hsiao, S.H., Chan, H.T., Do, Y.Y., Huang, P.L., Chang, H.W., Tsai, Y.C., Lin, C.M., Pang, V.F., Jeng, C.R., 2010. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet Immunol Immunopathol 135, 234-242. Chia, M.Y., Hsiao, S.H., Chan, H.T., Do, Y.Y., Huang, P.L., Chang, H.W., Tsai, Y.C., Lin, C.M., Pang, V.F., Jeng, C.R., 2011. Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs. Vet Immunol Immunopathol 140, 215–225. Cho, J.G., Dee, S.A., Deen, J., Guedes, A., Trincado, C., Fano, E., Jiang, Y., Faaberg, K., Collins, J.E., Murtaugh, M.P., Joo, H.S., 2006. Evaluation of the effects of animal age, concurrent bacterial infection, and pathogenicity of porcine reproductive and respirator syndrome virus on virus concentration in pigs. Am J Vet Res 67, 489-493. Chueh, L.L., Lee, K.H., Wang, F.I., Pang, V.F., Weng, C.N., 1998. Sequence analysis of the nucleocapsid protein gene of the porcine reproductive and respiratory syndrome virus Taiwan MD-00l strain. Adv Exp Med Biol 440, 795-799. Collins, J.E., Benfield, D.A., Christianson, W.T., Harris, L., Hennings, J.C., Shaw, D.P., Goyal, S.M., McCullough, S., Morrison, R.B., Joo, H.S., 1992. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in north America and experimental reproduction of the disease in gnotobiotic pigs. J Vet Diagn Invest 4, 117-126. Curtiss R.I. and Cardineau, G.A. 1990. Oral immunization by transgenic plants WO90/02484. Das, P.B., Dinh, P.X., Ansari, I.H., de Lima, M., Osorio, F.A., Pattnaik, A.K,, 2010. The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J Virol 84,1731-1740. Darwich, L., Diaz, I., Mateu, E., 2010. Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome Virus immunobiology. Virus Res 154, 123-132. Delputte. P.L., Costers, S., Nauwynck, H.J., 2005. Analysis of porcine reproductive and respiratory syndrome virus attachment and internalization: distinctive roles for heparan sulphate and sialoadhesin. J Gen Virol 86, 1441-1445. Diaz, I., Darwich, L., Pappaterra, G., Pujols, J., Mateu, E., 2005, Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. J Gen Virol 86, 1943-1951. Diaz, I., Pujols, J., Ganges, L., Gimeno, M., Darwich, L., Domingo, M., Mateu, E., 2009. In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nueleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus. Vaccine 27, 5603-5611. Done, S.H., Paton, D.J., White, M.E., 1996. Porcine reproductive and respiratory syndrome (PRRS) : a review, with emphasis on pathological, virological and diagnostic aspects. Br Vet J 152,153-174. Duan, X., Nauwynck, H.J, Favored, H., Pensacrt, M.B., 1998a. Porcine reproductive and respiratory syndrome virus intction of alveolar niacrophages can be blocked by monoclonal antibodies against cell surface antigens, Adv Exp Med Biol 440, 81-88. Duan, X., Nauwynck. H.J., Favoreel, H., Pensaert, M.B., 1998a. Porcine reproductive and respiratory syndrome virus infection of alveolar macrophages can be blocked by monoclonal antibodies against cell surface antigens. Adv Exp Med Biol 440, 81-88. Duan, X., Nauwynck, H.J., Favoreel, H,W., Pensaert, M.B., 1998b. Identification of a putative receptor for porcine reproductive and respiratory syndrome virus on porcine alveolar macrophages. J Virol 72, 4520-4523. Duan, X., Nauwynek, H.J., Pensaert, M.B., 1997. Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRsv). Arch Virol 142, 2483-2497. Faaberg, K.S., Hocker, J.D., Erdman, M.M., Harris, D.L., Nelson, E.A., Torremorell, M., Plagemann, P.G., 2006. Neutralizing antibody responses of pigs infected with natural GP5 N-glycan mutants of porcine reproductive and respiratory syndrome virus. Viral Immunol 19, 294-304. Fenaux, M., Halbur, P.G., Haqshenas, G., Royer, R., Thomas, P., Nawagitgui, P., Gill. M., Toth, T.E., Meng, X.J., 2002. Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions. J Virol 76, 541-551. Fischer, R., Emans, N., 2000. Molecular farming of pharmaceutical proteins. Transgenic Res 9, 279-299. Floss, D.M., Falkenburg, D., Conrad, U., 2007. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview transgenic Res 16, 315-332. Foss, D.L., Zilliox, M.J., Meier, W., Zuckermann, F., Murtaugh, M.P., 2002. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus. Viral Immunol 15, 557-566. Gonin, P., Pirzadeh. B., Gagnon, C.A., Dea, S., 1999. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. J Vet Diagn Invest 11, 20-26. Guo, A., Wu, G., Gong, W., Luo, X., Zheng, H., Jia, H., Cai, X., 2012. Outbreaks of highly pathogenic porcine reproductive and respiratory syndrome in Jiangxi province, China. Ir Vet J 65, 14. Halbur, P.G., Miller, LD., Paul, P.S., Meng, X.J., Huffman, E.L., Andrews, J.J., 1995. Immunohistochemical identification of porcine reproductive and respiratory syndrome virus (PRRSV) antigen in the heart and lymphoid system of three-week-old colostrum-deprived pigs. Vet Pathol 32, 200-204. Halbur, P.G., Paul, P.S., Frey, M.L., Landgraf, J., Eernisse, K., Meng, X.J., Andrews, J.J., Lum, M.A., Rathje, J.A., 1996. Comparison of the antigen distribution of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 33, 159-170. Halbur, P.G., Paul, P.S., Vaughn, E.M., Andrews, J.J., 1993. Experimental reproduction of pneumonia in gnotobiotic pigs with porcine respiratory coronavirus isolate AR310. J Vet Diagn Invest 5, 184-188. Haq, T.A., Mason, H.S., Clements, J.D., Arntzen, C.J., 1995. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268, 714-716. Hu, J., Ni, Y., Dryman, B. A., Meng, X.J., Zhang, C., 2012. Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 30, 2068– 2074. Jeong, H.J., Song. Y.J., Lee, S.W., Lee, J.B., Park, S.Y., Song, C.S., Ha, G.W., Oh, J.S., Oh. Y.K., Choi, I.S., 2010. Comparative measurement of cell-mediated immune responses Of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus. Clin Vaccine Immunol 17, 503-512. Jiang, P., Jiang, W., Li, Y., Wu. S., Xu. J., 2004, Humoral immune response induced by oral administration 0f S. typhimurium containing a DNA vaccine against porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 102, 321-328. Jiang, W., Jiang, P., Li, Y., Tang, J., Wang, X., Ma, S., 2006a. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet Immunol Immunopathol 113, 169- 1 80. Jiang, W., Jiang. P., Wang, X., Li, Y., Du, Y., Wang, X., 2008. Enhanced Immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus. Virus Res 136, 50-57. Jiang, Y., Fang, L., Xiao, S., Zhang, H., Pan, Y., Luo, R., Li, B., Chen, H., 2007. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine 25, 547-560. Jiang. Y., Xiao, S., Fang, L., Yu, X., Song, Y., Niu, C., Chen, H., 2006b. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 24,2869-2879. Kim, T.G., Kim, B.G., Kim, M.Y., Choi, J.K., Jung, E.S., Yang. M.S, 2010. Expression and jmmunogenicity of enterotoxigenic Escherichia coil heat-labile toxin B subunit in transgenic rice callus. Mol Biotechnol 44, 14-21. Kimman, T.G., Comelissen, L.A., Moormann, R.J., Rebel, J.M., Stockhofe-Zurwieden, N., 2009. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 27. 3704-3718. Labarque, G., Reeth, K.V., Nauwynck, H., Drexler, C., Van Gucht, S., Pensaert, M., 2004. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy . Vaccine 22, 4l83-4190. Li, Y., Wang, X., Bo, K., Wang, X., Tang, B., Yang, B., Jiang, W., Jiang, P., 2007. Emergence of a highly pathogenic porcine rcproductive and respiratory syndrome virus in the Mid-Eastern region of China. Vet J 174, 577-584. Lopez Fuertes, L., Domenech, N., Alvarez, B., Ezquerra, A., Domingue, J., Castro, J.M., Alonso, F., 1999. Analysis of cellular immune response in pigs recoverd from porcine respiratory and reproductive syndrome infection. Virus Res 64, 33-42. Mason, H.S., Warzecha, H., Mor, T., Arntzen C.J., 2002. Edble plant vaccines:applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 8, 324-329. Mateu, E., Diaz, I., 2008. The challenge of PRRS immunology. Vet J 177, 345-351. Meier, W.A., Galeota, J., Osorio, F.A., Husmann,R.J.,Schnitzlein, W.M., Zuckermann,F.A.,2003. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 309, 18-31. Meng, X.J., Paul, P.S., Halbur, P.G., Lum, M.A., 1995. Phylogenetic analyses of the putative M (ORF 6) and N (ORF 7) genes of porcine reproductive and respiratory syndrome virus (PRRSV):implication for the existence of two genotypes of PRRSV in the U.S.A. and Europe. Arch Virol 140, 745-755. Mengeling, W.L., Lager. K.M., Vorwald, AC., Clouser, D.F., 2003. Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for procine reproductive and respiratory syndrome. Vet Microbiol 93, 25-38. Meulenberg, J.J., Hulst, M.M., de Meijer, E.J., Moonen, P.L., den Besten, A., de K1uyver, EP., Wensvoort, G., Moormann, R.J., 1993. Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. Virology 192, 62-72. Meulenberg, J.J., Petersen den Besten, A., de Kluyver, E., van Nieuwstadt, A., Wensvoort, G., Moormann, Ri., I997. Molecular characterizatin of Lelystad virus. Vet Microbiol 55, 197-202. Murtaugh. M.P., Elam, M.R., Kakach, L.T., 1995. Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus. Arch Virol 140, 1451-1460. Murtaugh. M.P., Xiao, Z., Zuckermann, F., 2002. Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol 15, 533-547. Nauwynck, H.J., Duan, X., Favoreel, H.W., Van Oostveldt, P., Pensaert, MB., 1999. Entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages via receptor-mediated endocytosis. J Gen Virol 80, 297-305. Nedialkova. D.D., Ulferts, R., van den Born. E., Lauber, C., Gorbalenya. A.E., Ziebuhr. J., Snijder, E.J.. 2009. Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus-wide conservation of a replicative endoribonuclease. J Virol 83, 5671-5682. Nelsen, C.J., Murtaugh, M.P., Faaberg, K.S., 1999. Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J Virol 73, 270-280. Nelson, E.A., Christppher-Henning, J., Benfield, D.A., 1994. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus J Vet Diagn Invest 6, 410-415. Neumann, E.J., Kliebenstein, J.B., Johnson, CD., Mabry, J.W., Bush, E.J., Seitzinger, A.H., Green, A.L., Zimmerman, J.J., 2005. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc 227, 385-392. Ni, J., Yang, S., Bounlom, D., Yu. X., Zhou, Z., Song, J., Khamphouth V., Vatthana T., Tian, K., 2012. Emergence and pathogenicity of highly pathogenic porcine reproductive and respiratory Syndrome Virus in Vientiane , Lao People`s Democratic Republic. J Vet Diagn Invest 24, 349-354. Oleksiewicz, M.B., Botner, A., Toft, P., Normann, P., Storgaard, T., 2001. Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contain a cluster of B-cell epitopes. J Virol 75, 3277-3290. Osorio, F.A., Galeota, J.A., Nelson, E., Brodersen, B., Doster. A., Wills, R., Zuckermann, F., Laegreid, W.W,, 2002. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 302, 9-20. Ostrowski, M., Galeota, J.A., Jar, A.M., Platt, K.B., Osorio. F.A., Lopez. OJ., 2002. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol 76, 4241-4250. Pirzadeh, B., Dea, S., 1997. Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define liner neutralizing determinants. J Gen Virol 78, 1867-1873. Pirzadeh, B., Dea, S., 1998. Immune response in pigs vaccinated with plasmid DNA encoding ORl5 of porcine reproductive and respiratory syndrome virus. J Gen Virol 79, 989-999. Plagemann, P.G., 2004a. GP5 ectodomain epitope of porcine reproductive and respiratory syndrome virus, strain Lelystad virus. Virus Res 102, 225-230. Plagemann, P.G., 2004b. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 102, 263-275. Plagemann, P.G., Rowland, R.R., Faaberg, K.S., 2002. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol 147, 2327-2347. Reed, L.J. and Muench, H., 1938. A simple method of estimating fifty percent endpoints. Am. J. Hygiene 27, 493-497. Renuga, G., Thandapani A.B., Arul, A.J.K., 2014. Transgenic banana callus derived recombinant cholera toxin B Subunit-as potential vaccines. Int J Curr Sci 10, 61-68. Rossow, K.D., Benfield, D.A., Goyal, SM., Nelson, E.A., Christopher-Hennings. J., Collins, J.E., 1996a. Chronological immunohistochemical detection and localization of porcine reproductive and respiratory syndrome virus in gnotobiotic pigs. Vet Pathol 33, 551-556. Rossow, K.D., Collins, J.E., Goyal, S.M.,Nelson.E.A., Christopher-Hennings. J., Benfield, D.A., 1995. Pathogenesis of Porcine Reproductive and Respiratory Syndrome Virus Infection in Gnotobiotic Pigs. Vet Pathol 32, 361-373. Rossow, K.D., Laube, K.L., Goyal, S.M., Collins, J.E., 1996b. Fetal microscopic lesions in porcine reproductive and respiratory syndrome virus-induced abortion. Vet Pathol 33, 95-99. Royaee, A.R., Husmann, R.J., Dawson, H.D., Caizada-Nova, G., Schnitzlein, W.M., Zuckermann. F.A., Lunncy, J.K., 2004. Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Vet Immunol Immunotpathol 102, 199-216. Sanchez, C., Domenech, N., Vazquez, J., Alonso, F., Ezquerra, A., Dominguez, J., 1999. The porcine 2A10 antigen is holmologous to human CD163 and related to macrophage differentiation. J Immunol 162, 5230-5237. Shen, G., Jin. N. Ma, M., Jin, K., Zheng, M., Zhuang, T., Lu, H., Zhu, G., Jin, M.,Huo,X ,Qin, X., Yin, R., Li, C., Li, H., Li, Y., Han, Z,, Chen, Y., Jin, M, 2007. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine 1L-18. Vaccine 25, 4193-4202. Snijder, E.J., Meulenberg, J.J., 1998. The molecular biology of arteriviruses. J Gen Virol 79, 961-979. Spilman, M.S., Welbon, C., Nelson, E., Dokland, T., 2009. Cryo-electron tomography of porcine reproductive and respiratory syndrome virus: organization of the nucleocapsid. J Gen Virol 90, 527-535. Stevenson, G.W., Van Aistine, W.G., Kanitz, CL.. 1994. Characterization of infection with endemic porcine reproductive and respiratory syndrome virus in a swine herd. J Am Vet Med Assoc 204, 1938-1942. Stockhofe-Zurwieden, N., Navarro Camarro, J.A., Grosse-Beilage. E., Chavez, J.,Pohlenz, J., 1993. Uterine and placental alterations in pregnant sows assocatcd with the porcine epidemic abortion and respiratory syndrome (PEARS). Zentralblatt fur Veterinarmedizin. Reihe B. Zentralbl Veterinarmed B 40, 261-271. Sur, J.H., Doster, A.R., Christian, J.S., Galeota, J.A., Wills, R.W., Zimmerman, J.J., Osorio, F.A., 1997. Porcine reproductive and respiratory syndrome virus replicates in testicular germ cells, alters spermatogenesis, and induces germ cell death by apoptosis. J Virol 71, 9170-9179. Takikawa, N., Kobayashi, S., Ide, S., Yamane, Y., Tanaka, Y., Yamagishi, H., 1996. Detection of antibodies against porcine reproductive and respiratory syndrome (PRRS) virus in swine sera by enzyme-linked immunosorbent assay. J Vet Med Sci 58. 355-357. Thanawongnuwech, R., Halbur, P.G., Andrews, J.J., 1997. Immunohistochemical detection of porcine reproductive and respiratory syndrome virus antigen in neurovascular lesions. J Vet Diagn Invest 9, 334-337. Tian, K., Yu. X., Zhao, T., Feng, Y., Cao, Z., Wang, C., Hu, Y., Chen, X., Hu, D., Tian, X., Liu, D., Zhang, S., Deng, X., Ding, Y., Yang. L., Zhang, Y., Xiao, H., Qiao, M., Wang, B., Hou, L., Wang, X., Yang, X., Kang, L., Sun, M., Jin, P., Wang, S., Kitamura, Y., Yan, J., Gao, G.F., 2007. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PloS one 2, e526. Tian, X., Lu, G., Gao, F., Peng. H., Feng, Y., Ma, G., Bartlam, M., Tian, K., Yan, J., Hilgenfeld, R., Gao, G.F., 2009. Structure and cleavage speciticity of the chymotrypsin-like serine protease (3CLSP/nsp4) of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). J Mol Biol 392, 977-993. Tiwan, S., Mishra, D.K., Roy, S., Singh, A., Singh, P.K., Tuli. R., 2009. High level expression of a functionally active choleralera toxin B: rabies glycoprotein fusion protein in tobacco seeds. Plant Cell Rep 28, 1827-l836. Van Brcedam, W., Van Gorp, H., Zhang, J.Q., Crocker, P.R., Delputte, P.L., Nauwynck, H.J., 2010. The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. PLoS pathogens 6, el000730. Van Den Born, E., Guityaev, A.P., Snijder, E.J., 2004. Secondary structure and function of the 5`-proximal region of the equine arteritis virus RNA genome. RNA (New York, N.Y.) 10, 424-437. Van den Heuvel, M.M., Tensen, C.P., van As, J.H., Van den Berg, T.K., Fluitsma, D.M., Dijkstra, C.D., Dopp, E.A., Droste, A., Van Gaalen, F.A., Sorg, C., Hogger, P., Beelen, R.H., 1999. Regulation of CD 163 on human macrophagcs:cross-linking of CD 163 induces signaling and activation. J Leukoc Biol 66, 858-866. Van Gorp, H., Van Breedarn, W., Dclputte, P.L., Nauwynck, H.J., 2008. Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus. J Gen Virol 89, 2943-2953. Van Gorp, H., Van Breedarn, W., Dclputte, P.L., Nauwynck, H.J., 2009. The porcine reproductive and respiratory syndrome virus requires trafficking through CD163-postive early endosomes, hut not late endosomes. for productive jnfection. Arch Virol 154, 1939-1943. Vanderheijden, N., Delputte, P.L., Favoreel, H.W., Vandekerckhove, J., Van Damme, J., van Woensel, P.A., Nauwynck, H.J., 2003. Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J Virol 77, 8207-8215. Wensvoort, G.,Terpstra, C., Pol, J. M., ter Laak, E.A., Bloemraad, M., de Kluyver, E.P., Kragten, C., van Buiten, L., den Besten, A., Wagenaar, F., 1991. Mystery swine disease in The Netherlands: the isolation of Lelystad virus, Vet Q 13, 121 -130. Wills, R.W., Zimmennan, J.J., Yoon, K.J., Swenson, S.L., Hoffman, L.J., McGinley, M.J., Hill, H.T., Platt, K.B., 1997. Porcine reproductive and respiratory syndrome virus: routes of excretion. Vet Microbiol 57, 69-81. Wissink, E.H., Kroese, M.V., van Wijk, H.A., Rijsewijk, F.A., Meulenberg, J.J., Rottier, P.J., 2005. Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus. J Virol 79,12495-12506. Yang, L., Frey, M.L., Yoon, K.J., Zimmerman, J.J., Platt, K.B., 2000. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch Virol 145, 1599-1619. Yoon, I.J., Joo, H.S., Christianson, W.T., Kim, H.S., Collins, J.E., Morrison, R.B., Dial, G.D., 1992. An indirect fluorescent antibody test for the detection of antibody to swine infertility and respiratory syndrome virus in swine sera. J Vet Diagn Invest 4, 144-147. Yoon, I.J., Joo, H.S., Goyal, S.M., Molitor, T.W., 1994. A moditied serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. J Vet Diagn Invest 6, 289-292. Yoon, K.J., Wu, L.L., Zimmerman, J.J., Hill. H.T., Platt. K.B., 1996. Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infetion in pigs. Viral Immunol 9,51-63. Yoon, K.J., Wu, L.L., Zimmerman, J.J., Platt, KB., 1997. Field isolates of porcine reproductive and respiratory syndrome virus (PRRSV) vary in their susceptibility to antibody dependent enhancement (ADE) of infcction. Vet Microbiol 55, 277-287. Yoon, K.J.. Zimmernan, J.J., Swenson, S.L., McGinley, M.J., Eemisse, K.A., Brevik, A., Rhinehart, L.L, Frey, M.L., Hill, H.T., Plati, KB., 1995. Characterization of the humoral immune response to porcine reproductive and respiratory syndrome (PRRS) virus infection. J Vet Diagn Invest 7, 305-312. Yuan, S., Murtaugh, M.P., Schumann, F.A., Mickelson, D., Faabcrg, K.S., 2004. Characterization of heteroclite subgenomic RNAs associated with PRRSV infection. Virus Res 105, 75-87. Zhou. Y.J., Hao. X.F., Tian. Z.J., Tong, GZ., Yoo, D., An, T.Q., Zhou, T., Li, G.X., Qiu, H.J., Wei, T.C., Yuan, X.F., 2008. Highly virulent porcine reproductive and respiratory syndrome virus emerged in China. Transbound Emerg Dis 55, 152-164. Ziebuhr, J., Snijdcr. E.J., Gorbalenya, A.E., 2000. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 81. 853-879. Zimmennan, J.J., Yoon K.J., Pirtle, E.C., Wills, R.W., Sanderson, T.J., McGinley, M.J., 1997. Studies of porcine reproductive and respiratory syndrome (PRRS) virus infection in avian species. Vet Microbiol 55, 329-336. Zuckermann, F.A., Garcia. E.A., Luque, I.D., Christopher-Hennings. J., Doster. A. Brito. M, Osorio. F., 2007. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of garnma-IFN -producing cells and virological parameters of protection upon challenge. Vet Microhiol 123, 69-85. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56654 | - |
dc.description.abstract | 豬生殖與呼吸綜合症(Porcine reproductive and respiratory syndrome;PRRS)是自1987 年首度在美國及1990年在歐洲被報導的新興豬病,近年來已成為肆虐全球的豬隻病毒性疾病,本省亦於民國八十二年證實有本病的入侵。臨床上,本病主要造成母豬厭食、懷孕後期的流、死產和木乃伊胎、產下虛弱仔豬、懷孕周期延遲和增加幼豬離乳前的死亡率;對各年齡層豬隻可引起呼吸急促、發燒、間質性肺炎等類感冒症狀,罹病豬隻也常因二次性細菌或病毒感染造成病情加劇甚至死亡,豬生殖與呼吸綜合症為目前造成全球養豬產業嚴重損失的重大豬隻病毒疾病之一。PRRSV疫苗早在1990年已開始使用,但至目前為止,仍無法有效預防或控制PRRSV。疫苗控制 PRRSV的困難點為PRRSV是一種 RNA 病毒,其具有高度抗原變異性,使豬隻對於變異的病毒株無法產生足夠的免疫反應,加上PRRSV在宿主所誘發的免疫反應相當複雜,且具有迴避宿主免疫系統的機制,使發展有效疫苗具有相當困難性。之前的研究顯示表現PRRSV GP5-LTB(Escherichia coli heat-labile enterotoxin B subunit;大腸桿菌熱溶解性次單位B融合蛋白)基因轉殖菸草口服次單位疫苗,已能誘發有效的免疫反應和一定程度的保護力,但由於基因轉殖植物疫苗在製程上面臨台灣法規的限制,故本實驗以能夠於培養基上大量生長的菸草癒合組織等不同劑型給予豬隻,嘗試解決疫苗發展困境。本實驗設計為16隻3-4週齡無特定病原(specific pathogen free; SPF)豬隻以口服的方式,分別給予不同劑型之口服疫苗,疫苗劑型分別為:共同表現GP5-GP6及LTB基因轉殖菸草癒合組織(GP5-GP6-LTB tobacco callus);單獨表現GP5的基因轉殖菸草癒合組織(GP5 tobacco callus);共同表現GP5-GP6及LTB的基因轉殖菸草葉片之冷凍乾燥粉末(GP5-GP6-LTB lyophilized tobacco leaves);無動物蛋白表現的普通菸草(wild-type tobacco fresh leaves),每次間隔兩週共三次,於免疫8週後,攻毒3 x 104 TCID50/mL PRRSV田間毒,每隻豬鼻腔及肌肉注射各1 mL,在動物攻毒三週後犧牲採樣,進行基因轉殖植物癒合組織或冷凍乾燥粉末等不同劑型在豬隻的安全性和免疫效力評估。本實驗結果顯示,連續三次服用特定劑量的菸草癒合組織或冷凍乾燥粉末,於豬隻生長表現上並無不良影響。體液性免疫反應結果顯示,於攻毒前anti-PRRSV ORF7含量低於其Cut-off value 0.4,顯示豬隻為陰性未感染PRRSV,anti-PRRSV ORF7 antibody含量於第8週後明顯上升,推測其結果與攻毒有關;anti-PRRSV ORF5 antibody方面,在第3-8週間,A組數值持續略高於其他組別,顯示抗體含量有輕微上升趨勢,但統計上無顯著差異;而第6、8、9週連續稀釋的結果,亦顯示於第6週三組疫苗組皆略高於陰性陰性控制組,但未達顯著差異。在PRRSV含量檢測結果顯示,在血清、組織和周邊血液白血球的PRRSV含量,A、B、C三組普遍略高於控制組D組,統計上四組數值多無顯著差異。總結本動物實驗結果,於攻毒前可觀察到三組疫苗組有anti-PRRSV ORF5 antibody含量微幅上升,但未觀察到有顯著差異的基因轉殖菸草植物相關性抗PRRSV的免疫反應及保護力。 | zh_TW |
dc.description.abstract | Porcine reproductive and respiratory syndrome (PRRS), a disease initially described in the United States in 1987 and in Europe in 1990, has caused tremendous economic losses in the swine industry worldwide. PRRS was also diagnosed in Taiwan in 1993. The reproductive form of this disease is characterized by anorexia, late term abortions (days 107-112 of gestation), increased numbers of stillborn, mummified, weak-borne pigs, delayed return to estrus, and increased preweaning mortality. Pronounced hyperpnea, fever, interstitial pneumonia, and mild flu-like signs occur in nursing and growing pigs. Infection of PRRS virus (PRRSV) also predisposes pigs to bacterial and viral infection; therefore, PRRS has been one of the most economically significant viral diseases in the swine industry. Although PRRSV modified live-attenuated vaccines (MLV) and inactivated vaccines have been available in 1990s, the efficacy of both vaccines is limited. The control of PRRSV by vaccination is challenging because of the significant antigenic diversity known to exist among all strains of this RNA virus and the resultant insufficient generation of protective immunity toward heterologous PRRSV strains. The complicate evading immune mechanism by PRRSV makes it difficult to develop vaccine. Our previous study has demonstrated that GP5-LTB transgenic tobacco subunit vaccine could induce mucosal and systemic immune responses and offer acceptable protection against PRRSV infection in pigs. Due to the restrictions of Taiwan regulation on transgenic plant vaccines, different forms of transgenic tobacco plant callus provides the alternative way to resolve this problem. The objective of the present study was to investigate the immunogenicity and efficacy of GP5-GP6-LTB tobacco callus, GP5 tobacco callus, GP5-GP6-LTB lyophilized tobacco leaves, and wild-type tobacco fresh leaves after oral administration. Sixteen 4-6 week old pigs, seronegative for PRRSV, were randomly divided into 4 groups. Pigs were given orally three consecutive doses at a 2-week interval, then were intranasally and intramuscularly challenged with 2 ml of 3x104 TCID50/mL PRRSV at 8 weeks post-initial immunization (WPI) and sacrified 3 weeks later. The efficacy of the three different types of transgenic tobacco plant was evaluated based on clinical parameter, immune responses as well as viral load. The result of changes in the body weights and daily weight gain showed no statistical significance among groups, and no clinical signs were observed throughout the study. In humoral immunity, the levels of serum anti-PRRSV ORF7 antibodies and anti-PRRSV ORF5 antibodies in three vaccinated groups elevated gradually after the intranasal and intramuscular challenge with PRRSV inoculation. The levels of serum anti-PRRSV ORF5 antibodies in three vaccinated groups elevated mildly from week 3 to week 8. In serial dilution test, the levels of serum anti-PRRSV ORF5 antibodies in three vaccinated groups did not have statistically significant differences from control group, while the three vaccinated groups generally showed slightly higher than control group at week 6. The levels of PRRSV viral load of serum, tissues and peripheral blood mononuclear cells of the GP5-GP6-LTB tobacco callus, GP5 tobacco callus, and GP5-GP6-LTB lyophilized tobacco leaf groups were not significantly different from the control group (wild-type tobacco fresh leaves). In summary, the present study has demonstrated that various types of transgenic plants could induce slightly low level of anti-PRRSV antibody. However, no detectable statistically significant vaccine-associated anti-PRRSV immunogenicity and protection in the pigs treated with the various types of transgenic plants. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T05:40:12Z (GMT). No. of bitstreams: 1 ntu-103-R01644006-1.pdf: 3248192 bytes, checksum: 5456a0e9a8fec2019dd19a2046fc47b0 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 中文摘要…………………………………………………………………………………………i
英文摘要………………………………………………………………………………………iii 目錄……………………………………………………………………………………………… vi 表次………………………………………………………………………………………… viii 圖次………………………………………………………………………………………… viii 第一章 序言…………………………………………………………………………1 第二章 文獻回顧……………………………………………………………………2 第一節 豬生殖與呼吸道綜合症之歷史背景和流行病學………2 第二節 豬生殖與呼吸道綜合症病毒的分類和結構組成………3 第三節 豬生殖與呼吸道綜合症致病機轉……………………...……5 第四節 豬生殖與呼吸道綜合症臨床症狀和病理變化…………………6 第五節 豬生殖與呼吸道綜合症病毒體對免疫系統的影響………………8 第六節 豬生殖與呼吸道綜合症疫苗的發展歷史和次單位疫苗的概述…9 第三章 實驗材料與方法……………………………………………13 第一節 實驗設計………………………………………………………………13 第二節 實驗材料………………………………………………………………15 2.1 實驗動物…………………………………………………………15 2.2 基因轉殖菸草口服次單位疫苗………15 2.3 病毒……………………………………………………………………………15 第三節 實驗方法………………………………………………………………16 3.1 樣本採集與處理………………………………………………………………………………………………16 3.2 酵素連結吸附免疫分析法 PRRSV ORF7-specific IgG………………17 3.3 酵素連結吸附免疫分析法 PRRSV ORF5-specific IgG………………17 3.4 組織病毒含量測定……………………………………………………………………………………………17 3.5 血清病毒含量測定………………………………………………………………………………………………19 3.6肉眼及組織病理學檢……………………………………………………………………………………………19 第四章 結果……………………………………………………………………………………………………………20 第一節 基因轉殖菸草癒合組織之安全性評估………………………………………………20 第二節 體液性免疫反應………………………………………………………22 2.1 酵素連結吸附免疫分析法檢測 PRRSV ORF7-specific IgG……22 2.2 酵素連結吸附免疫分析法檢測 PRRSV ORF5-specific IgG……22 2.3酵素連結吸附免疫分析法檢測連續稀釋倍數血清之anti-PRRSV ORF5-specific IgG…………………………………………………………………25 第三節 疫苗保護效力分析……………………………………………27 3.1 血清病毒含量……………………………………………………………27 3.2 組織病毒含量……………………………………………………………27 3.3 周邊血液白血球病毒含量………………………………………30 3.4 組織病理學檢查…………………………………………………………30 第五章 討論……………………………………………………………………33 第六章 參考文獻……………………………………………………………40 | |
dc.language.iso | zh-TW | |
dc.title | 豬隻口服豬生殖與呼吸綜合症病毒GP5-GP6與大腸桿菌熱溶解性腸毒素次單位B(LTB)融合蛋白之基因轉殖菸草癒合組織之免疫效力評估 | zh_TW |
dc.title | Evaluation of the immunogenicity and efficacy in pigs fed with a transgenic plant callus expressing the recombinant fusion proteins of porcine reproductive and respiratory syndrome virus GP5-GP6 and Escherichia coli heat-labile enterotoxin B subunit | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 龐飛(Victor-Fei Pang) | |
dc.contributor.oralexamcommittee | 張志成(Chih-Cheng Chang),劉涓(Jiuan Liu),黃有良(Yu-Liang Huang),張惠雯(Hui-Wen Chang) | |
dc.subject.keyword | 豬生殖與呼吸綜合症,基因轉殖菸草口服次單位疫苗,共同表現GP5-GP6及LTB基因轉殖菸草癒合組織,單獨表現GP5的基因轉殖菸草癒合組織,共同表現GP5-GP6及LTB的基因轉殖菸草葉片之冷凍乾燥粉末,無動物蛋白表現的普通菸草, | zh_TW |
dc.subject.keyword | Porcine reproductive and respiratory syndrome,transgenic tobacco subunit vaccine,GP5-GP6-LTB tobacco callus,GP5 tobacco callus,GP5-GP6-LTB lyophilized tobacco leaves,wild-type tobacco fresh leaves, | en |
dc.relation.page | 57 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-08-12 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 分子暨比較病理生物學研究所 | zh_TW |
顯示於系所單位: | 分子暨比較病理生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 3.17 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。